Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ViaDerm-hPTH (1-34) vs. Forteo in postmenopausal osteoporosis
NCT00535860Phase 2Completed
- Sponsor
- TransPharma Medical Ltd.
- Start
- Apr 2008
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of teriparatide in osteoporosis, sponsored by TransPharma Medical Ltd.. Started Apr 2008; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00535860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535860.